MedPath

Feasibility study: identification of silent aspiration in acute stroke

Not Applicable
Completed
Conditions
Stroke
Circulatory System
Registration Number
ISRCTN99184189
Lead Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust
Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37158000/ (added 18/08/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Are admitted to the Royal Victoria Infirmary Hyper-Acute Stroke Unit (HASU) with a suspected or confirmed diagnosis of a new stroke
2. Are sufficiently alert to tolerate clinical swallow examination or cough reflex testing (i.e. able to maintain alertness for at least 20 minutes)
3. Have adequate head control and are able to tolerate being positioned upright for the duration of the assessment
Also:
4. Due to service restrictions, patients are required to have their swallowing assessment during working hours of Speech and Language Therapists carrying out cough reflex testing
5. Patients who are known to have high intracranial pressure will be discussed with the treating consultant prior to assessment as this is a potential contraindication for performing the test as per the protocol described by Miles and colleagues (2013)
6. Participants must have English as their primary language
7. Consent will be obtained prior to the assessment or the assessment will be completed in the participant's best interests if they are unable to consent (informed consent obtained)

Exclusion Criteria

1. Are under 18 years of age
2. Are medically deteriorating or being treated palliatively
3. Are too agitated to engage in assessment
4. Have a history of previous silent aspiration identified on instrumental swallow assessment
5. Are unable to provide informed consent to participate in the study and do not have an appropriate spokesperson to provide consent on their behalf
6. Have a structural anomaly that could interfere with swallowing
7. Are more than 3 days post-stroke
8. COVID-19 suspected or confirmed

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath